Equity Overview
Price & Market Data
Price: $3.65
Daily Change: -$0.24 / 6.58%
Daily Range: $3.52 - $3.92
Market Cap: $13,928,327
Daily Volume: 36,124
Performance Metrics
1 Week: -8.29%
1 Month: -25.81%
3 Months: 15.51%
6 Months: 0.55%
1 Year: -85.53%
YTD: -57.36%
Company Details
Employees: 28
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.